Literature DB >> 29484378

Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7.

Xin-Long Wang1, Yuan-Yuan Zhao1, Li Sun1, Yu Shi1, Zhu-Qian Li1, Xiang-Dong Zhao2, Chang-Gen Xu2, Hong-Ge Ji2, Mei Wang1, Wen-Rong Xu1, Wei Zhu1.   

Abstract

It has been previously reported that exosomes derived from human umbilical cord mesenchymal stem cells (hucMSC)‑exosomes exhibit cardioprotective effects on the rat acute myocardial infarction (AMI) models and cardiomyocyte hypoxia injury models in vitro, however the exact mechanisms involved require further investigation. The present study aimed to investigate the repair effects of hucMSC‑exosomes on myocardial injury via the regulation of mothers against decapentaplegic homolog 7 (Smad7) expression. Compared with sham or normoxia groups (in vivo and in vitro, respectively), western blotting demonstrated that Smad7 expression was significantly decreased in the borderline area of infraction myocardium and in H9C2(2‑1) cells following hypoxia‑induced injury. Additionally, microRNA (miR)‑125b‑5p expression was markedly increased using reverse transcription‑quantitative polymerase chain reaction, but was reversed by hucMSC‑exosomes. Trypan blue staining and lactate dehydrogenase release detection demonstrated that cell injury was significantly increased in the AMI + PBS and hypoxia group compared with in the sham and normoxia groups and was inhibited by hucMSC‑exosomes. A dual luciferase reporter gene assay confirmed that Smad7 is a target gene of miR‑125b‑5p. In addition, miR‑125b‑5p mimics promoted H9C2(2‑1) cell injury following 48 h exposure to hypoxia. Downregulation of Smad7 expression under hypoxia was increased by miR‑125b‑5p mimics compared with the mimic negative control, and hucMSC‑exosomes partially alleviated this phenomenon. In conclusion, hucMSC‑exosomes may promote Smad7 expression by inhibiting miR‑125b‑5p to increase myocardial repair. The present study may provide a potential therapeutic approach to improve myocardial repair following AMI.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29484378     DOI: 10.3892/ijmm.2018.3496

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

1.  Human umbilical cord mesenchymal stem cells-derived exosomes transfers microRNA-19a to protect cardiomyocytes from acute myocardial infarction by targeting SOX6.

Authors:  Lin Huang; Lu Yang; Yin Ding; Xinghua Jiang; Zhen Xia; Zhigang You
Journal:  Cell Cycle       Date:  2020-01-10       Impact factor: 4.534

Review 2.  Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.

Authors:  Susmita Sil; Raghubendra Singh Dagur; Ke Liao; Eric S Peeples; Guoku Hu; Palsamy Periyasamy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

3.  MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis.

Authors:  Yubao Liu; Lupan Lin; Rui Zou; Chuanyang Wen; Zhen Wang; Fuqing Lin
Journal:  Cell Cycle       Date:  2018-11-11       Impact factor: 4.534

4.  miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.

Authors:  Huajie Zong; Huading Zhou; Yang Xiang; Gang Wu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 5.  Gene therapy for cardiovascular diseases in China: basic research.

Authors:  Jiali Deng; Mengying Guo; Guoping Li; Junjie Xiao
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

Review 6.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

Review 7.  Biomimetic and immunomodulatory therapeutics as an alternative to natural exosomes for vascular and cardiac applications.

Authors:  Ramiro A Villarreal-Leal; John P Cooke; Bruna Corradetti
Journal:  Nanomedicine       Date:  2021-03-24       Impact factor: 6.096

8.  Exosomes Derived from TIMP2-Modified Human Umbilical Cord Mesenchymal Stem Cells Enhance the Repair Effect in Rat Model with Myocardial Infarction Possibly by the Akt/Sfrp2 Pathway.

Authors:  Jing Ni; Xijun Liu; Yiheng Yin; Peiyu Zhang; Ya-Wei Xu; Zheng Liu
Journal:  Oxid Med Cell Longev       Date:  2019-04-28       Impact factor: 6.543

Review 9.  Perspectives for Future Use of Extracellular Vesicles from Umbilical Cord- and Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells in Regenerative Therapies-Synthetic Review.

Authors:  Joanna Lelek; Ewa K Zuba-Surma
Journal:  Int J Mol Sci       Date:  2020-01-25       Impact factor: 5.923

Review 10.  Interplay between Exosomes and Autophagy in Cardiovascular Diseases: Novel Promising Target for Diagnostic and Therapeutic Application.

Authors:  Jinfan Tian; Mohammad Sharif Popal; Yingke Zhao; Yanfei Liu; Keji Chen; Yue Liu
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.